Wei Jiao Selected Research

urinastatin (MR 20)

11/2023	Effects of ulinastatin therapy in deep vein thrombosis prevention after brain tumor surgery: A single-center randomized controlled trial.
7/2023	Ulinastatin in the treatment of severe acute pancreatitis: A single-center randomized controlled trial.
2/2023	Effects of ulinastatin therapy in emergency severe multiple trauma: A single-center randomized controlled trial.
1/2022	Ulinastatin alleviates early brain injury after intracerebral hemorrhage by inhibiting necroptosis and neuroinflammation via MAPK/NF-κB signaling pathway.
1/2022	Ulinastatin alleviates early brain injury after intracerebral hemorrhage by inhibiting oxidative stress and neuroinflammation via ROS/MAPK/Nrf2 signaling pathway.
1/2022	Ulinastatin alleviates early brain injury after traumatic brain injury by inhibiting oxidative stress and apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei Jiao Research Topics

Disease

29	Neoplasms (Cancer) 03/2024 - 01/2013
8	Neoplasm Metastasis (Metastasis) 12/2022 - 01/2013
7	Neuroinflammatory Diseases 01/2023 - 01/2021
6	Urinary Bladder Neoplasms (Bladder Cancer) 03/2024 - 02/2013
6	Inflammation (Inflammations) 01/2023 - 09/2017
6	Brain Injuries (Brain Injury) 01/2023 - 09/2021
5	Kidney Neoplasms (Kidney Cancer) 01/2021 - 01/2013
4	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2023 - 09/2021
4	Brain Edema (Cerebral Edema) 01/2023 - 01/2021
4	Myasthenia Gravis 04/2022 - 01/2018
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2013
4	Prostatic Neoplasms (Prostate Cancer) 04/2020 - 01/2013
4	Hemifacial Spasm 09/2012 - 03/2012
3	Rheumatoid Arthritis 06/2023 - 01/2022
3	Experimental Arthritis 02/2023 - 01/2022
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 12/2017
3	Breast Neoplasms (Breast Cancer) 12/2022 - 05/2015
3	Infections 02/2022 - 07/2016
3	Fatigue 01/2022 - 01/2019
3	Cerebral Hemorrhage 01/2022 - 11/2021
3	Trigeminal Neuralgia (Tic Douloureux) 07/2014 - 05/2012
3	Echinococcosis (Hydatid Cysts) 04/2014 - 12/2002
2	Hyperplasia 06/2023 - 02/2023
2	Stroke (Strokes) 02/2023 - 11/2021
2	Carcinoma (Carcinomatosis) 11/2022 - 12/2020
2	Intraoperative Complications 08/2022 - 11/2020
2	Necrosis 01/2022 - 02/2018
2	Pain (Aches) 01/2022 - 05/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 10/2017
2	Nasopharyngeal Carcinoma 12/2021 - 01/2013
2	Muscle Weakness 07/2021 - 01/2021
2	Overactive Urinary Bladder (Overactive Bladder) 01/2021 - 08/2019
2	Lymphatic Metastasis 04/2020 - 02/2016
2	Spasm (Spasms) 01/2013 - 09/2012
1	Venous Thromboembolism 03/2024
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2023
1	Vomiting 11/2023
1	Diarrhea 11/2023
1	Brain Neoplasms (Brain Tumor) 11/2023
1	Dehydration (Water Stress) 10/2023
1	Pancreatitis 07/2023
1	Osteoarthritis 06/2023
1	Erectile Dysfunction 05/2023
1	Compression Fractures (Compression Fracture) 04/2023
1	Rupture 04/2023
1	Urolithiasis 03/2023

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 12/2022 - 10/2012
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2013
8	CytokinesIBA 01/2023 - 10/2017
6	urinastatin (MR 20)IBA 11/2023 - 01/2022
5	Messenger RNA (mRNA)IBA 11/2023 - 01/2013
4	Interleukin-6 (Interleukin 6)IBA 02/2023 - 01/2022
4	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 09/2021
4	MicroRNAs (MicroRNA)IBA 12/2021 - 09/2017
3	Tumor Biomarkers (Tumor Markers)IBA 12/2022 - 01/2019
3	Long Noncoding RNAIBA 12/2021 - 01/2020
3	qiangji jianliIBA 01/2021 - 01/2018
3	AntigensIBA 04/2020 - 10/2013
2	yishen-tongbi decoctionIBA 06/2023 - 04/2023
2	ErianinIBA 01/2023 - 01/2022
2	CollagenIBA 01/2023 - 01/2022
2	Pyruvate CarboxylaseIBA 01/2023 - 01/2022
2	Small Interfering RNA (siRNA)IBA 12/2022 - 02/2013
2	EnzymesIBA 10/2022 - 01/2018
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2019
2	dihydroarteannuinIBA 01/2022 - 01/2022
2	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2022 - 01/2022
2	Caspase 3 (Caspase-3)IBA 01/2022 - 01/2021
2	Therapeutic UsesIBA 01/2022 - 05/2020
2	Peptides (Polypeptides)IBA 09/2020 - 01/2018
2	LigandsIBA 01/2019 - 02/2016
2	Circulating Tumor DNAIBA 01/2019 - 01/2019
2	QuercetinIBA 01/2019 - 12/2017
2	Plant ExtractsIBA 01/2019 - 02/2018
2	AntibodiesIBA 01/2018 - 10/2013
2	AlkaloidsIBA 04/2014 - 02/2013
2	nitidineIBA 04/2014 - 10/2013
1	AnticoagulantsIBA 03/2024
1	Thromboplastin (Tissue Factor)IBA 03/2024
1	B7-H1 AntigenIBA 11/2023
1	6-methyladenineIBA 11/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2023
1	AlcoholsIBA 10/2023
1	peoniflorinIBA 10/2023
1	yishenIBA 06/2023
1	IntegrinsIBA 06/2023
1	Tadalafil (Cialis)FDA Link 05/2023
1	Bone Cements (Bone Glue)IBA 04/2023
1	Methotrexate (Mexate)FDA LinkGeneric 04/2023

Therapy/Procedure

14	Therapeutics 03/2024 - 03/2012
8	Microvascular Decompression Surgery 07/2014 - 03/2012
3	Length of Stay 11/2023 - 07/2016
3	Immunotherapy 11/2023 - 04/2021
2	Cystectomy 08/2022 - 02/2022
2	Operative Time 08/2022 - 11/2020
1	Acupuncture Points (Acupuncture Point) 05/2023
1	X-Ray Film 04/2023
1	Kyphoplasty 04/2023
1	Urinary Diversion (Ileal Conduit) 03/2023